FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Eugia US Triamcinolone Acetonide Injectable Suspension Recall

Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL M…

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Oct 11, 2023
Recall ID
D-0041-2024
Check your lot numberHow we source this data

Summary

Eugia US recalled Triamcinolone Acetonide Injectable Suspension starting Sep 28, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0041-2024 on Oct 11, 2023. Reason: Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Product description

Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.

Lot numbers, UPCs & expiration codes

Lot #: 3TC22010, Exp 11/30/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0041-2024
Classification
Class II
Status
Ongoing
Recall initiated
Sep 28, 2023
FDA report date
Oct 11, 2023
Quantity
1,626 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0041-2024, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
93128
Address
279 Princeton Hightstown Rd
Code information
Lot #: 3TC22010, Exp 11/30/2024
Postal code
08520-1401
Report date
Oct 11, 2023
Product type
Drugs
Recall number
D-0041-2024
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
1,626 vials
Reason for recall
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 28, 2023
Center classification date
Oct 5, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0041-2024, published Oct 11, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls